α-trocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669

Cancer Letters

Volumn 127, Issue 1-2, 1998, Pages 107-112

  Van Rensburg, Constance E J ^a   Jooné, Gisela ^a   Anderson, Ronald ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Tocopherol; Clofazimine; Cyclosporin A; Multidrug resistance; Verapamil

Indexed keywords

3 ANILINO 2 CYCLOHEXYLIMINO 2,10 DIHYDRO 10 PHENYLPHENAZINE; ALPHA TOCOPHEROL; CLOFAZIMINE; CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; VERAPAMIL; VINBLASTINE; ACRIDINE DERIVATIVE; CYCLOSPORIN; DRUG DERIVATIVE; ELACRIDAR; ISOQUINOLINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; CELL CULTURE; CELL DEATH; LUNG TUMOR; METABOLISM;

ACRIDINES; CELL DEATH; CLOFAZIMINE; CYCLOSPORINE; DRUG RESISTANCE, MULTIPLE; HUMANS; ISOQUINOLINES; LUNG NEOPLASMS; TETRAHYDROISOQUINOLINES; TUMOR CELLS, CULTURED; VERAPAMIL; VINBLASTINE; VITAMIN E;

EID: 0032523229     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00020-2     Document Type: Article

References (13)

1. Greenberger L.M. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12. J. Biol. Chem. 268:1993;11417-11425.
2. Drori S., Eytan G.D., Assaraf Y.G. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur. J. Biochem. 228:1995;1020-1029.
3. 2, free fatty acids and lysophospholipids. Ann. N. Y. Acad. Sci. 570:1989;121-135.
4. Hyafil F., Vergely C., Du Vignaud P., Grand-Perret T. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53:1993;4595-4602.
5. Twentyman P.R., Wright K.A., Wallace H.M. Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug-resistant human lung cancer cells in vitro. Br. J. Cancer. 65:1992;335-340.
6. Twentyman P.R., Fox N.E., Wright K.A., Bleehen N.M. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. Br. J. Cancer. 53:1986;529-537.
7. Van Rensburg C.E.J., Anderson R., Myer M.S., Joone G.K., O'Sullivan J.F. The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line. Cancer Lett. 85:1994;59-63.
8. Hamada H., Tsuruo T. Functional role of the 170 to 180 kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 83:1986;7785-7787.
9. Erin A.N., Spirin M.M., Tabidze L.V., Kagan V.E. Formation of α-tocopherol complexes with fatty acids: a hypothetical mechanism of stabilization of biomembranes by vitamin E. Biochim. Biophys. Acta. 774:1984;96-102.
10. Cao Y.Z., Karmin O., Choy P.C., Chan A.C. Regulation by vitamin E of phosphatidylcholine metabolism in rat heart. Biochem. J. 247:1989;135-140.
11. Reddanna P., Whelan J., Burgess J.R., Eskrew M.L., Hildenbrandt G., Zarkower A., Scholz R.W., Reddy C.C. The role of vitamin E and selenium on arachidonic acid oxidation by way of the 5-lipoxygenase pathway. Ann. N. Y. Acad. Sci. 570:1989;136-145.
12. Boscoboinik D., Szewczyk A., Azzi A. α-Tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 286:1991;264-269.
13. Scuntaro I., Kientsch U., Wiesmann U.N., Honegger U.E. Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells. Br. J. Pharmacol. 119:1996;829-834.